A first-in-human study of MIL95, an anti-CD47 monoclonal antibody (mAb), in patients with advanced solid tumors and lymphomas

被引：0
|
作者：
Zhang, Qingyuan
Liu, Aiguo
Shi, Jianhua
Cai, Qingqing
Qu, Zerui
Liu, Sijun
Song, Yuqin
机构：
[1] Harbin Med Univ Canc Hosp, Harbin, Peoples R China
[2] Anhui Jimin Canc Hosp, Hefei, Peoples R China
[3] Linyi Canc Hosp, Dept Med Oncol, Linyi, Shandong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[5] Beijing Mabworks Biotech Co Ltd, Beijing, Peoples R China
[6] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14513
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase Ia/Ib trial of the anti-PD-L1 human monoclonal antibody (mAb), CS1001, in patients (pts) with advanced solid tumors or lymphomas.
    Shen, Lin
    Cao, Junning
    Li, Jin
    Pan, Hongming
    Xu, Nong
    Zhang, Yan
    Wang, Jingru
    Wang, Yin
    Dai, Hangjun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors
    Papadopoulos, Kyriakos P.
    Kelley, Robin Kate
    Tolcher, Anthony W.
    Razak, Albiruni R. Abdul
    Van Loon, Katherine
    Patnaik, Amita
    Bedard, Philippe L.
    Alfaro, Ariceli A.
    Beeram, Muralidhar
    Adriaens, Lieve
    Brownstein, Carrie M.
    Lowy, Israel
    Kostic, Ana
    Trail, Pamela A.
    Gao, Bo
    DiCioccio, A. Thomas
    Siu, Lillian L.
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1348 - 1355
  • [43] A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas
    Gounder, Mrinal M.
    Bauer, Todd M.
    Schwartz, Gary K.
    Weise, Amy M.
    LoRusso, Patricia
    Kumar, Prasanna
    Tao, Ben
    Hong, Ying
    Patel, Parul
    Lu, Yasong
    Lesegretain, Arnaud
    Tirunagaru, Vijaya G.
    Xu, Feng
    Doebele, Robert C.
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1714 - +
  • [44] A5 phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αV integrins, in patients with solid tumors.
    Jayson, GC
    Mullamitha, S
    Ton, C
    Valle, J
    Hope, L
    Jackson, A
    Parker, G
    Roberts, C
    Julyan, P
    Munteanu, M
    Davis, H
    Nemeth, J
    Prabhaker, U
    Lang, Z
    Beckman, RA
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8966S - 8966S
  • [45] A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients
    Fisher, George A.
    Lakhani, Nehal J.
    Eng, Cathy
    Hecht, J. Randolph
    Bendell, Johanna C.
    Philip, Philip Agop
    O'Dwyer, Peter J.
    Johnson, Benny
    Kardosh, Adel
    Ippolito, Tina M.
    Wang, Yan V.
    Agoram, Balaji
    Volkmer, Jens-Peter
    Maute, Roy
    Chico, Isagani
    Chao, Mark
    Takimoto, Chris H. M.
    Patnaik, Amita
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [46] Phase I evaluation of a fully human anti-αv integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors
    Mullamitha, Saifee A.
    Ton, Nhuan C.
    Parker, Geoff J. M.
    Jackson, Alan
    Julyan, Peter J.
    Roberts, Caleb
    Buonaccorsi, Gio A.
    Watson, Yvonne
    Davies, Karen
    Cheung, Sue
    Hope, Lynn
    Valle, Juan W.
    Radford, John A.
    Lawrance, Jeremy
    Saunders, Mark P.
    Munteanu, Mihaela C.
    Nakada, Marian T.
    Nemeth, Jeffrey A.
    Davis, Hugh M.
    Jiao, Qun
    Prabhakar, Uma
    Lang, Zhihui
    Corringham, Robert E.
    Beckman, Robert A.
    Jayson, Gordon C.
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2128 - 2135
  • [47] First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors
    Kathleen N. Moore
    Johanna C. Bendell
    Patricia M. LoRusso
    Anthony J. Olszanski
    Esther Zwick-Wallasch
    Mendel Jansen
    Alexander G. Vandell
    Giorgio Senaldi
    Investigational New Drugs, 2019, 37 : 147 - 158
  • [48] First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors
    Moore, Kathleen N.
    Bendell, Johanna C.
    LoRusso, Patricia M.
    Olszanski, Anthony J.
    Zwick-Wallasch, Esther
    Jansen, Mendel
    Vandell, Alexander G.
    Senaldi, Giorgio
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (01) : 147 - 158
  • [49] First-in-human study of PM14 in patients with advanced solid tumors.
    Vieito, Maria
    Aix, Santiago Ponce
    Paz-Ares, Luis G.
    Bahleda, Rastilav
    Massard, Christophe
    Agreda, Leyre
    Banus, Eva
    Fernandez, Cristian Marcelo
    Cristoveanu, Elena Y.
    Corral, Gema
    Llanero, Lourdes
    Lubomirov, Rubin
    Kahatt, Carmen Maria
    Fudio, Salvador
    Nieto, Antonio
    Cullell-Young, Martin
    Zeaiter, Ali Hassan
    Oberoi, Honey Kumar
    Garralda, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
    Andres Forero
    Johanna C. Bendell
    Prasanna Kumar
    Linda Janisch
    Michael Rosen
    Qiang Wang
    Catherine Copigneaux
    Madhuri Desai
    Giorgio Senaldi
    Michael L. Maitland
    Investigational New Drugs, 2017, 35 : 298 - 306
12345